Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
Kymera Therapeutics (KYMR) - Net assets
Net assets on the balance sheet as of December 2023 : $0.39 B
According to Kymera Therapeutics's latest financial reports the company has $0.39 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Kymera Therapeutics - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.39 B | -19.42% |
| 2022-12-31 | $0.49 B | 6.64% |
| 2021-12-31 | $0.45 B | 61.91% |
| 2020-12-31 | $0.28 B | -481.54% |
| 2019-12-31 | $-74.41 M | 116.07% |
| 2018-12-31 | $-34.44 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -43.26% | 🇺🇸 USA |